What This Report
Will Provide?
This study involved four major
activities in estimating the current size of the oligonucleotide synthesis market. Exhaustive
secondary research was carried out to collect information on the market, its
peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with
industry experts across the value chain through primary research. Both top-down
and bottom-up approaches were employed to estimate the complete market size.
After that, market breakdown and data triangulation procedures were used to
estimate the size of segments and subsegments.
Expected Revenue Growth:
[230 Pages Report] The global oligonucleotide
synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3
billion in 2019, at a CAGR of 13.7%.
Major Growth Boosters:
This market is experiencing
significant growth due to the increasing research activities in the pharma and
biotech sectors and the rising demand for innovative diagnostic and therapeutic
techniques.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350
Recent Developments:
In Febuary 2019, Thermo Fisher Scientific entered into an agreement with
BioNTech (Germany). Under the terms of this agreement, BioNTech’s messenger RNA
(mRNA) manufacturing platform will be supported by Thermo Fisher through the
supply of nucleotides, enzymes, and other critical raw materials
In Febuary 2019, IDT expanded its courier zones of free next-day delivery
service to scientists based in Cambridge, Oxford, and London. This service
expansion will help IDT increase its customer base, and also enable projects to
be started and finished sooner.
In March 2018, Danaher acquired IDT, whichenhanced Danaher’s Life Sciences
platform and expanded its customer base.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global oligonucleotide synthesis market?
2. What are the drivers, restraints, opportunities, and challenges in the oligonucleotide synthesis
Industry?
3. What are the opportunities for stakeholders and provide details of the
competitive landscape for key players?
4. What will be growth of oligonucleotide
synthesis in North America, Europe, Asia Pacific, Latin America, and the
Middle East and Africa?
Regional Growth Analysis:
The global oligonucleotide synthesis industry is segmented into North America, Europe, the Asia
Pacific, Latin America, and the Middle East & Africa. In 2018, North
America was the largest market for share, followed by Europe. Moreover, North
America is estimated to register the highest CAGR during the forecast period
primarily due to the increasing R&D activities and the growing number of
oligonucleotide-based drugs/therapies being approved by the FDA.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350
Key Players in Oligonucleotide Synthesis Market:
The prominent players operating in this market include Agilent
Technologies, Inc. (US), ATDBio Ltd. (UK), Bio-Synthesis, Inc. (US),
BioAutomation Corporation (US), LGC Biosearch Technologies (US), Biogen
International (US), Sarepta Therapeutics (US), Eurofins Genomics (Germany), Eurogentec (Belgium),
GeneDesign, Inc. (Japan), GE Healthcare (US), GenScript, Inc. (US), Integrated
DNA Technologies (IDT, US), Nitto Denko Avecia, Inc. (US), Sarepta Therapeutics
(US), Thermo Fisher Scientific, Inc. (US), TriLink BioTechnologies (US), and
Sigma-Aldrich Corporation (US) (a part of Merck KGAA).